How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review

Lupattelli, 2014, Medication use in pregnancy: a cross-sectional, multinational web-based study, BMJ Open, 4, 10.1136/bmjopen-2013-004365 Maeda, 2008, Use and cost of medication in low risk pregnant women, Rev Latino-Am Enferm, 16, 266, 10.1590/S0104-11692008000200015 Haas, 2018, Prescription and other medication use in pregnancy, Obstet Gynecol, 131, 789, 10.1097/AOG.0000000000002579 Mitchell, 2011, Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008, Am J Obstet Gynecol, 205, 51.e1, 10.1016/j.ajog.2011.02.029 Heslehurst, 2007, Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period, BJOG, 114, 187, 10.1111/j.1471-0528.2006.01180.x Jackson, 2023, Pharmacoepidemiology and costs of medications dispensed during pregnancy: a retrospective population-based study, BJOG, 130, 1317, 10.1111/1471-0528.17472 Adam, 2011, Evolving knowledge of the teratogenicity of medications in human pregnancy, Am J Med Genet C Semin Med Genet, 157C, 175, 10.1002/ajmg.c.30313 Curran, 1971, The thalidomide tragedy in Germany: the end of a historic medicolegal trial, N Engl J Med, 284, 481, 10.1056/NEJM197103042840906 Lynch, 1990, Diethylstilbestrol, teratogenesis, and carcinogenesis: medical/legal implications of its long-term sequelae, including third generation effects, Int J Risk Saf Med, 1, 171, 10.3233/JRS-1990-1301 Casassus, 2017, France bans sodium valproate use in case of pregnancy, Lancet, 390, 217, 10.1016/S0140-6736(17)31866-4 Cohen, 2006, Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment, JAMA, 295, 499, 10.1001/jama.295.5.499 Khalifeh, 2016, Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry, Lancet Psychiatr, 3, 233, 10.1016/S2215-0366(16)00003-1 O'Brien, 2009, Estimating the economic costs of antidepressant discontinuation during pregnancy, Can J Psychiatry, 54, 399, 10.1177/070674370905400607 Laue-Gizzi, 2021, Discontinuation of antiepileptic drugs in adults with epilepsy, Aust Prescr, 44, 53, 10.18773/austprescr.2021.005 Davies, 2020, Medicines prescribed for asthma, discontinuation and perinatal outcomes, including breastfeeding: a population cohort analysis, PLoS One, 15, 10.1371/journal.pone.0242489 van der Zande, 2017, Vulnerability of pregnant women in clinical research, J Med Ethics, 43, 657, 10.1136/medethics-2016-103955 Wisner, 2020, Pregnant women are still therapeutic orphans, World Psychiatr, 19, 329, 10.1002/wps.20776 Kazma, 2023, Pharmacoethics and pregnancy: overcoming the therapeutic orphan stigma, Br J Clin Pharmacol, 89, 483, 10.1111/bcp.15173 Stika, 2012, Chapter 24: drug therapy in pregnant and nursing women World Health Organization, 2023 2023 Crear-Perry, 2021, Social and structural determinants of health inequities in maternal health, J Womens Health (Larchmt), 30, 230, 10.1089/jwh.2020.8882 Doran, 2008, Australian pharmaceutical policy and the idea of innovation, J Aust Polit Econ, 62, 39 Lacetera, 2001, Political regimes, technological regimes and innovation in the evolution of the pharmaceutical industry in the USA and in Europe Dalton, 2001, Australia's pharmaceutical benefits system: flawed but improving, and better than anywhere else, Aust Health Rev, 24, 7, 10.1071/AH010007 Sachdeva, 2009, Drug use in pregnancy; a point to ponder, Indian J Pharm Sci, 71, 1, 10.4103/0250-474X.51941 World Health Organization, 2016 Grant, 2009, A typology of reviews: an analysis of 14 review types and associated methodologies, Health Info Libr J, 26, 91, 10.1111/j.1471-1842.2009.00848.x Paré, 2017, Chapter 9: methods for literature reviews Cassell, 2005, Report on the 6th international conference on grey literature, Collect Build, 24, 70, 10.1108/01604950510592698 Farace, 1997 Australian Government, 2023 Pan, 2007, In Google we trust: users' decisions on rank, position, and relevance, J Computer-Mediated Commun, 12, 801, 10.1111/j.1083-6101.2007.00351.x 2022 Feghali, 2015, Pharmacokinetics of drugs in pregnancy, Semin Perinatol, 39, 512, 10.1053/j.semperi.2015.08.003 Fisk, 2008, Market failure and the poverty of new drugs in maternal health, PLoS Med, 5, e22, 10.1371/journal.pmed.0050022 Shields, 2013, Exclusion of pregnant women from industry-sponsored clinical trials, Obstet Gynecol, 122, 1077, 10.1097/AOG.0b013e3182a9ca67 Department of Health and Aged Care, 2023 Therapeutic Goods Administration, 2022 Therapeutic Goods Administration, 2011 Therapeutic Goods Administration, 2022 Tan, 2016, Managing nausea and vomiting in pregnancy in a primary care setting, Aust Fam Physician, 45, 564 Hsiao, 2021, Pregnant women report being denied medications to treat severe nausea and vomiting of pregnancy or hyperemesis gravidarum—findings from an Australian online survey, Aust N Z J Obstet Gynaecol, 61, 616, 10.1111/ajo.13359 Council of Australian Therapeutic Advisory Groups, 2013 Department of Health and Aged Care Brekke, 2022, Quality of Life instruments and their psychometric properties for use in parents during pregnancy and the postpartum period: a systematic scoping review, Health Qual Life Outcome, 20, 107, 10.1186/s12955-022-02011-y Leal, 2017, How externalities impact an evaluation of strategies to prevent antimicrobial resistance in health care organizations, Antimicrob Resist Infect Control, 6, 53, 10.1186/s13756-017-0211-2 Hensher, 2020, Incorporating environmental impacts into the economic evaluation of health care systems: perspectives from ecological economics, Resour Conserv Recycl, 154, 10.1016/j.resconrec.2019.104623 Goldhaber-Fiebert, 2015, Evaluating cost-effectiveness of interventions that affect fertility and childbearing: how health effects are measured matters, Med Decis Making, 35, 818, 10.1177/0272989X15583845 Abel, 2022, A pregnant pause: rethinking economic evaluation in contraception and pregnancy, Value Health, 25, 32, 10.1016/j.jval.2021.07.009 Iedema, 2021, Effect of a state hospital formulary on medicines utilisation in Australia, Aust Health Rev, 45, 704, 10.1071/AH20330 2022 Australian Government Department of Health, 2016 Department of Health and Aged Care, 2022 Parliament of Australia, 2002 Colvin, 2013, Off-label use of ondansetron in pregnancy in Western Australia, BioMed Res Int, 2013, 10.1155/2013/909860 2020, 2022 Nursing and Midwifery Board, 2023 Department of Health and Aged Care, 2023 2020, Task force on research specific to pregnant women and lactating women (PRGLAC) Food and Drug Administration, 2015 2019 2019 2019 2021, Medicines for pregnancy-specific conditions: research, development and market analysis Yakerson, 2019, Women in clinical trials: a review of policy development and health equity in the Canadian context, Int J Equity Health, 18, 56, 10.1186/s12939-019-0954-x van Diemen, 2021, The importance of achieving sex- and gender-based equity in clinical trials: a call to action, Eur Heart J, 42, 2990, 10.1093/eurheartj/ehab457 Habibzadeh, 2022, Disparity in the selection of patients in clinical trials, Lancet, 399, 1048, 10.1016/S0140-6736(22)00176-3 van der Graaf, 2018, Fair inclusion of pregnant women in clinical trials: an integrated scientific and ethical approach, Trials, 19, 78, 10.1186/s13063-017-2402-9 Department of Health and Aged Care, 2022 Duckett, 2015 Parody-Rua, 2020, Economic evaluations informed exclusively by real world data: a systematic review, Int J Environ Res Public Health, 17, 10.3390/ijerph17041171 Bowrin, 2019, Cost-effectiveness analyses using real-world data: an overview of the literature, J Med Econ, 22, 545 2017 1994, Committee on ethical and legal issues relating to the inclusion of women in clinical studies. 2. Women's participation in clinical studies